Zurcher Kantonalbank (Zurich Cantonalbank) Beam Therapeutics Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$34.1 Billion
Q4 2024

A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 22,629 shares of BEAM stock, worth $596,047. This represents 0.0% of its overall portfolio holdings.

Number of Shares

22,629

Previous 21,396 5.76%

Holding current value

$596,047

Previous $524,000 7.06%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 07, 2025	BUY	$21.55 - $30.35 $26,571 - $37,421	1,233 Added 5.76%	22,629 $561,000
Q3 2024 Nov 07, 2024	BUY	$22.57 - $33.14 $11,646 - $17,100	516 Added 2.47%	21,396 $524,000
Q2 2024 Jul 29, 2024	SELL	$21.22 - $32.66 $4,689 - $7,217	-221 Reduced 1.05%	20,880 $489,000
Q1 2024 Apr 25, 2024	BUY	$23.46 - $45.07 $8,820 - $16,946	376 Added 1.81%	21,101 $697,000
Q4 2023 Jan 30, 2024	BUY	$17.69 - $30.76 $155,990 - $271,241	8,818 Added 74.06%	20,725 $564,000
Q3 2023 Oct 25, 2023	BUY	$23.01 - $32.46 $35,642 - $50,280	1,549 Added 14.95%	11,907 $286,000
Q2 2023 Aug 07, 2023	BUY	$29.32 - $35.99 $2,521 - $3,095	86 Added 0.84%	10,358 $330,000
Q1 2023 May 08, 2023	BUY	$30.15 - $48.79 $22,612 - $36,592	750 Added 7.88%	10,272 $314,000
Q4 2022 Feb 01, 2023	SELL	$36.73 - $51.6 $2,901 - $4,076	-79 Reduced 0.82%	9,522 $372,000
Q3 2022 Nov 09, 2022	SELL	$39.79 - $70.31 $41,302 - $72,981	-1,038 Reduced 9.76%	9,601 $457,000
Q2 2022 Aug 09, 2022	BUY	$29.86 - $62.36 $31,143 - $65,041	1,043 Added 10.87%	10,639 $412,000
Q1 2022 Apr 21, 2022	BUY	$53.73 - $82.16 $20,417 - $31,220	380 Added 4.12%	9,596 $550,000
Q4 2021 Feb 01, 2022	BUY	$68.02 - $99.06 $92,031 - $134,028	1,353 Added 17.21%	9,216 $734,000
Q3 2021 Nov 15, 2021	BUY	$84.37 - $133.6 $53,153 - $84,168	630 Added 8.71%	7,863 $684,000
Q2 2021 Jul 30, 2021	BUY	$64.12 - $128.71 $99,514 - $199,757	1,552 Added 27.32%	7,233 $931,000
Q1 2021 May 03, 2021	BUY	$71.28 - $120.75 $251,119 - $425,402	3,523 Added 163.25%	5,681 $455,000
Q4 2020 Jan 28, 2021	BUY	$22.24 - $95.63 $47,993 - $206,369	2,158 New	2,158 $176,000

Others Institutions Holding BEAM

# of Institutions

253

Shares Held

78.6M

Call Options Held

304K

Put Options Held

142K

View Full List

About Beam Therapeutics Inc.

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.85B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

More about BEAM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account

Zurcher Kantonalbank (Zurich Cantonalbank) Beam Therapeutics Inc. Transaction History